Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
14.36
+0.22 (1.56%)
At close: Aug 3, 2026

SHE:301408 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
801.07957.971,0021,336482.1284.51
Trading Asset Securities
198221012.41-0.5
Cash & Short-Term Investments
999.07979.971,0121,349482.1285.01
Cash Growth
-6.08%-3.13%-24.99%179.76%69.16%23.37%
Accounts Receivable
581.28588.83472.6513.14470.77294.32
Other Receivables
56.049.68.8136.2434.5230.82
Receivables
637.32598.43481.42549.38505.29325.14
Inventory
1,0891,055863.84772.09545.01436.19
Prepaid Expenses
-13.5515.638.272.524.22
Other Current Assets
257.24266.34224.87147.78165.2262.74
Total Current Assets
2,9822,9132,5972,8261,7001,113
Property, Plant & Equipment
976.28985967.8870.15533.42542.53
Long-Term Investments
45.5245.5282.292.8125.458.92
Goodwill
1,2821,282988.37609.31190.06190.06
Other Intangible Assets
63.1563.967.2162.51338.26
Long-Term Deferred Tax Assets
56.2651.7840.6532.8321.9215.17
Long-Term Deferred Charges
82.8182.9659.0352.1158.9792.32
Other Long-Term Assets
62.3463.8425.4865.7413.230.5
Total Assets
5,5515,4884,8284,6122,5761,971

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,7501,6661,1581,027698.74468.23
Accrued Expenses
59.4174.24140.2599.84101.6879.98
Short-Term Debt
267.26345.3316.92513.51340.31150.77
Current Portion of Long-Term Debt
357.43179.36116.0210.25--
Current Portion of Leases
-199.71210.44193.64154.24144
Current Income Taxes Payable
66.0138.1420.6312.334.6313.15
Current Unearned Revenue
35.5842.8637.1127.0619.4111.25
Other Current Liabilities
112.9939.74178.9480.3112.715.25
Total Current Liabilities
2,6492,6862,1791,9641,362882.64
Long-Term Debt
437.15407.08358.83331.1518.95-
Long-Term Leases
209.05220.08222.85237.65248.51303.03
Long-Term Unearned Revenue
1.751.810.810.91--
Long-Term Deferred Tax Liabilities
6.16.26.656.32--
Other Long-Term Liabilities
4.54.5-95.4-0.33
Total Liabilities
3,3073,3252,7682,6351,6291,186

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
400.01400.01400.01400.01340340
Additional Paid-In Capital
916.8916.8977.861,014194.7192.99
Retained Earnings
859.51780.17627.42529.39412.58251.81
Total Common Equity
2,1762,0972,0051,944947.28784.8
Minority Interest
67.4366.1355.1433-0.270.25
Shareholders' Equity
2,2442,1632,0601,977947.01785.05
Total Liabilities & Equity
5,5515,4884,8284,6122,5761,971

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,2711,3521,2251,286762.02597.8
Net Cash (Debt)
-271.83-371.57-213.4362.53-279.92-312.8
Net Cash Growth
------
Net Cash Per Share
-0.68-0.93-0.530.16-0.82-0.94
Filing Date Shares Outstanding
400.01400.01400.01400.01340340
Total Common Shares Outstanding
400.01400.01400.01400.01340340
Working Capital
333.52227.37418.84862.52338.42230.65
Book Value Per Share
5.445.245.014.862.792.31
Tangible Book Value
830.76750.67949.711,272724.22586.49
Tangible Book Value Per Share
2.081.882.373.182.131.72
Buildings
-382.39219.2238.7323.1523.15
Machinery
-337.07297.24270.1679.3865.74
Construction In Progress
-34.73168.6661.3432.240.25